Pure Biologics SA (PUR1)

Warsaw
Currency in PLN
14.08
-0.38(-2.63%)
Closed
PUR1 Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
Fair Value
Day's Range
13.8214.48
52 wk Range
6.3533.20
Key Statistics
Edit
Bid/Ask
14.00 / 14.08
Prev. Close
14.46
Open
14.38
Day's Range
13.82-14.48
52 wk Range
6.35-33.2
Volume
101.95K
Average Volume (3m)
76.92K
1-Year Change
37.5%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PUR1 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Pure Biologics SA Company Profile

Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurological autoimmune disorders, including neuromyelitis optica and myasthenia gravis; and provides contract research for pharmaceutical and biotechnology companies. Pure Biologics S.A. was incorporated in 2010 and is headquartered in Wroclaw, Poland.

Compare PUR1 to Peers and Sector

Metrics to compare
PUR1
Peers
Sector
Relationship
P/E Ratio
−1.2x−5.0x−0.7x
PEG Ratio
−0.03−0.050.00
Price/Book
−10.6x2.0x2.6x
Price / LTM Sales
−5.0x11.3x3.1x
Upside (Analyst Target)
-73.2%45.9%
Fair Value Upside
Unlock5.8%8.3%Unlock

Earnings

Latest Release
May 15, 2023
EPS / Forecast
-2.29 / --
Revenue / Forecast
29.00K / --
EPS Revisions
Last 90 days

FAQ

What Is the Pure Biologics (PUR1) Stock Price Today?

The Pure Biologics stock price today is 14.08

What Stock Exchange Does Pure Biologics Trade On?

Pure Biologics is listed and trades on the Warsaw stock exchange.

What Is the Stock Symbol for Pure Biologics?

The stock symbol for Pure Biologics is "PUR1."

What Is the Pure Biologics Market Cap?

As of today, Pure Biologics market cap is 52.78M.

What is Pure Biologics Earnings Per Share?

The Pure Biologics EPS is -5.93.

From a Technical Analysis Perspective, Is PUR1 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.